Marc J. Yoskowitz

SVP, Strategy & Corporate Dev, Hospira.

Companies

Keenova Therapeutics plcBoard member Aug 4, 2025 to now¹
Mereo BioPharma Group plcBoard member Jan 2, 2024 to now²
HospiraSVP, Strategy & Corporate Dev Aug 20, 2014 to Sep 3, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Keenova Therapeutics plc3,541 shares⁴Jun 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 2, 2026Shares withheld for tax 825 shares of Keenova Therapeutics plc⁴
Jun 2, 2026Exercised options 3,579 shares of Keenova Therapeutics plc⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKeenova Therapeutics plc, Board member
2
SEC EDGARMereo BioPharma Group plc, Board member
3
SEC EDGARHospira, SVP, Strategy & Corporate Dev
4
SEC EDGARKeenova Therapeutics plc shares after the filing of Jun 2, 2026